Saturday 17 October 2026
Export DMAC’s income statement to Excel — free account
DiaMedica Therapeutics, Inc.
DMAC Healthcare Biotechnology
In the quarter to June 2026, EPS fell 5.56%, free cash flow fell 6.75% and total debt fell 90.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.57
0.47
−5.85%
Follow DMAC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
10.55 | 11.72 | 8.98 | 6.63 | |
Current Ratio |
10.67 | 11.81 | 9.11 | 6.72 | |
Net Debt/EBITDA |
5.97 | 6.33 | 4.81 | 4.08 | |
Debt/Assets |
0.01% | 0.01% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.76 | 0.89 | 0.90 | 0.80 | |
Capex/Depreciation |
0.07 | 0.02 | 0.04 | 0.02 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (0.17) | (0.17) | (0.15) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.13) | (0.17) | (0.17) | (0.15) | |
Cash per Share |
1.11 | 1.27 | 0.95 | 0.81 | |
Shareholders Equity per Share |
1.04 | 1.19 | 0.88 | 0.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.04 | 1.19 | 0.88 | 0.71 | |
Free Cash Flow |
(6.57) | (7.77) | (9.09) | (8.12) | |
Working Capital |
50.96 | 55.50 | 46.62 | 37.72 | |
Capital Expenditures |
(0.02) | (0.01) | (0.01) | 0.00 | |
Net Current Asset Value |
50.80 | 55.37 | 46.52 | 37.65 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.28 | 0.25 | 0.28 | 0.20 | |
Average Payables |
1.55 | 1.21 | 2.40 | 2.04 | |
Average Assets |
54.79 | 53.86 | 45.96 | 38.24 | |
Average Common Equity |
49.79 | 48.41 | 40.59 | 32.75 |
Columns are period end dates